This disclosure is being filed pursuant to Regulation 30 of the Listing Regulations, to inform you that the Board of Directors of Alkem Medtech Private Limited ('AMPL' or 'Transferee Company'), a wholly owned subsidiary of Alkem Laboratories Limited ('Company') has, at its meeting held on 6th February, 2026 approved the amalgamation of Alkem Medtech Ortho Private Limited ('AMOPL' or 'Transferor Company'), a wholly owned subsidiary of the Transferee Company, with and into the Transferee Company by way of a scheme of arrangement pursuant to the provisions of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (including the rules thereunder) ('Scheme'), and in compliance with the provisions of the Income Tax Act, 1961.